Sale of Securities

Amylyx Pharmaceuticals, Inc. Filed 2026-11-09 Acc 0001950047-26-010867

Documents 1

2026-11-12 4 Chief Financial Officer sold 40,000 shares at an average $30.19 ($1,207,742)
2026-11-12 4 Co-Chief Executive Officer sold 100,000 shares at an average $29.84 ($2,983,838)
2026-11-12 4 Co-Chief Executive Officer sold 100,000 shares at an average $29.84 ($2,983,678)
2026-11-09 144 Sale of Securities
2026-11-09 144 Sale of Securities
2026-11-09 144 Sale of Securities
2026-11-05 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…